Gisela Canedo-Marroquín

Pontificia Universidad Católica de Chile — Chile

Medicine · Health Sciences

10h-index595citations17works11.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Respiratory viral infections research(6), COVID-19 Clinical Research Studies(3), SARS-CoV-2 and COVID-19 Research(3), Neonatal Respiratory Health Research(3), Pneumonia and Respiratory Infections(3)

Publications17 total

The Intersection of the Oral Microbiome and Salivary Metabolites in Head and Neck Cancer: From Diagnosis to Treatment
Cancers·2024· 8 citedOpen Access
New insights into the role of the oral leukoplakia microenvironment in malignant transformation
Frontiers in Oral Health·2024· 15 citedOpen Access
Corrigendum: Exploring the therapeutic potential of the mitochondrial transfer-associated enzymatic machinery in brain degeneration
Frontiers in Physiology·2023Open Access
Exploring the therapeutic potential of the mitochondrial transfer-associated enzymatic machinery in brain degeneration
Frontiers in Physiology·2023· 4 citedOpen Access
Challenges in gastrointestinal research in Latin America
Nature Reviews Gastroenterology & Hepatology·2023· 4 citedOpen Access
Increased Heme Oxygenase 1 Expression upon a Primary Exposure to the Respiratory Syncytial Virus and a Secondary Mycobacterium bovis Infection
Antioxidants·2022· 4 citedOpen Access
Periodontitis and Gestational Diabetes Mellitus: A Potential Inflammatory Vicious Cycle
International Journal of Molecular Sciences·2021· 47 citedOpen Access
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile
Clinical Infectious Diseases·2021· 109 citedOpen Access
Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice
Frontiers in Cellular and Infection Microbiology·2021· 10 citedOpen Access
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial
2021· 59 citedOpen Access
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
Frontiers in Immunology·2020· 36 citedOpen Access
Current Insights in the Development of Efficacious Vaccines Against RSV
Frontiers in Immunology·2020· 41 citedOpen Access
Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection
Frontiers in Immunology·2019· 99 citedOpen Access
Role of Regulatory T Cells in Infection and Vaccination During Early Infancy
Current Pharmaceutical Design·2018· 2 cited
Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity
Frontiers in Cellular and Infection Microbiology·2017· 29 citedOpen Access
Heme Oxygenase-1 Modulates Human Respiratory Syncytial Virus Replication and Lung Pathogenesis during Infection
The Journal of Immunology·2017· 66 citedOpen Access
A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice
Vaccine·2017· 62 citedOpen Access

Frequent Co-authors

Alexis M. Kalergis(11), Susan M. Bueno(7), Jorge A. Soto(5), Catalina A. Andrade(5), Nicolás M. S. Gálvez(4), Claudia A. Riedel(4), Pablo A. González(3), Gaspar A. Pacheco(3), Roslye V. Berríos-Rojas(3), Farides Saavedra(3), Margarita K. Lay(3), Katia Abarca(2), Luisa F. Duarte(2), Bárbara M. Schultz(2), Liliana A González(2), Mariana Ríos(2), Felipe Melo-González(2), Daniela Rivera-Pérez(2), Carolina Iturriaga(2), Marcela Urzúa(2)